Literature DB >> 15351785

Antigen-independent acquisition of MHC class II molecules by human T lymphocytes.

Anita H Undale1, Peter J van den Elsen, Esteban Celis.   

Abstract

We report here that human T lymphocytes have the capacity of acquiring large amounts of MHC class II molecules from various types of antigen-presenting cells (APC) in an antigen-independent manner. The transfer of MHC class II molecules from APC to T cell required direct cell-to-cell contact and appeared to involve the interaction of numerous adhesion molecules between these cells. Depletion of cholesterol from the plasma membrane reduced the amount of MHC class II transferred onto the T cells. Most significantly, the newly acquired MHC class II molecules were capable of efficiently presenting antigen to T helper cells. These results suggest that T cells are able to interact with other T cells to regulate immune responses by presenting MHC peptide complexes that have been snatched away from nearby APC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15351785      PMCID: PMC1986719          DOI: 10.1093/intimm/dxh154

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  41 in total

Review 1.  The bare lymphocyte syndrome and the regulation of MHC expression.

Authors:  W Reith; B Mach
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  Acquisition of CD80 by human T cells at early stages of activation: functional involvement of CD80 acquisition in T cell to T cell interaction.

Authors:  Zohreh Tatari-Calderone; Roshanak Tolouei Semnani; Thomas B Nutman; Jeffrey Schlom; Helen Sabzevari
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

3.  Intercellular exchange of class II MHC complexes: ultrastructural localization and functional presentation of adsorbed I-A/peptide complexes.

Authors:  D M Patel; R W Dudek; M D Mannie
Journal:  Cell Immunol       Date:  2001-11-25       Impact factor: 4.868

Review 4.  Intercellular transfer of antigen-presenting cell determinants onto T cells: molecular mechanisms and biological significance.

Authors:  Denis Hudrisier; Pierre Bongrand
Journal:  FASEB J       Date:  2002-04       Impact factor: 5.191

5.  Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes.

Authors:  H Kropshofer; S Spindeldreher; T A Röhn; N Platania; C Grygar; N Daniel; A Wölpl; H Langen; V Horejsi; A B Vogt
Journal:  Nat Immunol       Date:  2001-12-17       Impact factor: 25.606

6.  Antigen presentation by mouse CD4+ T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion?

Authors:  Julia Y S Tsang; Jian Guo Chai; Robert Lechler
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

7.  Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III.

Authors:  Tjadine M Holling; Nienke van der Stoep; Edwin Quinten; Peter J van den Elsen
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

8.  Inhibition of EBV-induced lymphoproliferation by CD4(+) T cells specific for an MHC class II promiscuous epitope.

Authors:  Ryusuke Omiya; Chantal Buteau; Hiroya Kobayashi; Carlos V Paya; Esteban Celis
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

9.  MHC class II-peptide complexes and APC lipid rafts accumulate at the immunological synapse.

Authors:  Elizabeth M Hiltbold; Neil J Poloso; Paul A Roche
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

10.  Intracytoplasmic domains of MHC class II molecules are essential for lipid-raft-dependent signaling.

Authors:  Stéphane Bécart; Niclas Setterblad; Suzanne Ostrand-Rosenberg; Santa J Ono; Dominique Charron; Nuala Mooney
Journal:  J Cell Sci       Date:  2003-06-15       Impact factor: 5.285

View more
  5 in total

1.  Dendritic cells derived from bone marrow cells fail to acquire and present major histocompatibility complex antigens from other dendritic cells.

Authors:  Penelope A Bedford; Fiona Burke; Andrew J Stagg; Stella C Knight
Journal:  Immunology       Date:  2008-02-07       Impact factor: 7.397

2.  Novel exosome-targeted CD4+ T cell vaccine counteracting CD4+25+ regulatory T cell-mediated immune suppression and stimulating efficient central memory CD8+ CTL responses.

Authors:  Siguo Hao; Yongqing Liu; Jinying Yuan; Xueshu Zhang; Tianpei He; Xiaochu Wu; Yangdou Wei; Deming Sun; Jim Xiang
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

3.  CD4(+) T cell-released exosomes inhibit CD8(+) cytotoxic T-lymphocyte responses and antitumor immunity.

Authors:  Haifeng Zhang; Yufeng Xie; Wei Li; Rajni Chibbar; Sidong Xiong; Jim Xiang
Journal:  Cell Mol Immunol       Date:  2010-12-13       Impact factor: 11.530

4.  Chronic lymphocytic leukemia (CLL) cells genetically modified to express B7-1, ICAM-1, and LFA-3 confer APC capacity to T cells from CLL patients.

Authors:  Mary T Litzinger; Kenneth A Foon; Helen Sabzevari; Kwong-Yok Tsang; Jeffrey Schlom; Claudia Palena
Journal:  Cancer Immunol Immunother       Date:  2008-11-14       Impact factor: 6.968

5.  Induction of a Regulatory Phenotype in CD3+ CD4+ HLA-DR+ T Cells after Allogeneic Mixed Lymphocyte Culture; Indications of Both Contact-Dependent and -Independent Activation.

Authors:  Anne Louise Schacht Revenfeld; Rikke Bæk; Malene Møller Jørgensen; Kim Varming; Allan Stensballe
Journal:  Int J Mol Sci       Date:  2017-07-24       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.